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Summary 
Natural killer (NK) cells have been defined as CD3e - ,CD16 + and/or CD56 § lymphocytes that 
mediate major histocompatibility complex (MHC)-unrestricted cytotoxicity against certain tumors 
and virus-infected cells. Unlike T lymphocytes, NK cells do not rearrange or productively express 
T cell antigen receptor genes. Moreover, NK cells from adults have been reported to not express 
CD3% & or e proteins on the cell surface or in the cytoplasm. Nonetheless, NK cells have been 
shown to share a number  of antigenic  and functional  similarities  to T  cells  that  suggest  the 
possibility of common origins.  In this report,  we demonstrate  that  functional  NK cells exist 
in liver at early stages of human embryonic development. Freshly isolated fetal NK cells mediated 
MHC-unrestricted cytotoxicity against NK-sensitive targets and acquired the ability to lyse NK- 
resistant tumors after overnight culture in interleukin 2. Unlike adult NK cells, freshly isolated 
fetal liver NK cells  and clones derived from these cells,  as well as a subset of cord blood NK 
cells, express substantial levels of CD36 and CD3e proteins in the cytoplasm. Expression of CD3e 
and CD3~ transcripts and cytoplasmic proteins in fetal NK clones was confirmed by polymerase 
chain reaction and Western blot analysis.  These findings  support the concept that  NK and T 
cells may arise from  a common progenitor  that  expresses components  of the CD3 complex. 
Alternatively,  it is possible that  the cytoplasmic CD36,e § fetal NK cells  represent  a distinct 
subpopulation  of NK cells  that  is predominant  in the fetus, but replaced by the cytoplasmic 
CD3~,e-  adult  NK cell population  after embryogenesis. 
N 
'K  cells I  are  a  subpopulation  of lymphocytes  arising 
from bone marrow progenitor  cells  that  are distinct 
from the progenitors of T and B cells (1). NK cells have the 
capacity to kill certain  tumors and virus-infected cells,  but 
unlike CTL, do not require the presence of MHC class I or 
II antigens to recognize their targets.  In addition  to medi- 
ating cytolytic function, activated NK cells produce regula- 
tory cytokines and growth factors, including  IFN-%  GM- 
CSF, and TNF-o~ (2). The receptors on the membrane of NK 
cells that are responsible for recognition of tumors or virus- 
infected  targets  are presently  unknown.  NK cells do  not 
rearrange TCR genes and do not express CD3E on the cell 
surface (3-8). Human NK cells can be identified by the pheno- 
type  membrane  CD3e-  (mCD3e)  and  CD16 §  and/or 
CD56 + (9). Mature NK cells have been reported to not ex- 
1 Throughout this article, the term NK cell will be used to designate 
lymphocytes with the antigenic phenotype (mCD3e- ,CD56" ), which 
includes both CD16- and CD16  § NK cell subsets. 
press CD3y,/~,e proteins,  but do express CD3~" in associa- 
tion  with  FcyRIII (CD16)  (10,  11). 
Although TCR rearrangement  clearly distinguishes ma- 
ture NK and T  lymphocytes,  it is possible that  these cells 
arise  from a common progenitor before the rearrangement 
events that commit cells to the T  lineage.  While there has 
been extensive analysis  of T  lymphocyte development, par- 
ticularly in the thymus, there has been essentially no infor- 
mation concerning NK cell ontogeny or differentiation.  In 
this study, we have documented the existence and character- 
istics of functional NK cells present in human embryonic and 
fetal  hematopoietic  tissues. 
Materials and Methods 
Preparation of Lymphofftes.  Embryonic and fetal tissues were ob- 
tained from elective therapeutic abortions. Gestation age was de- 
termined  by crown-rump  length  and ranged  from 6 to 24 wk. 
Mononuclear cells from fetal liver, spleen, and thymus were pre- 
pared by standard Ficoll-Hypaque procedures and cells suspended 
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ville, MD],  10%  FCS [JR  Scientific, Woodland, CA],  1 mM 
t-glutamine, and 1% penicillin-streptomycin). Fetal tissues were 
obtained and used with the approval of the Committee for the Pro- 
tection of Human Subjects at our institutes, Adult peripheral blood 
was obtained from the Stanford Blood Center (Palo Alto, CA). 
Mononudear cells from cord blood of full-term newborns and pe- 
ripheral blood of healthy adults were isolated by standard Ficoll- 
Hypaque techniques. Monocytes and B cells were depleted by ad- 
herence to plastic and nylon wool, and large low buoyant density 
cells were isolated by centrifugation through discontinuous gra- 
dients of Percoll (Pharmacia Fine Chemicals, Piscataway,  NJ), as 
previously described (12). 
mAbs.  mAbs  against the following antigens were used: CD1 
(anti-Leu-6); CD2 (anti-Leu-Sb);  CD3e (anti-Leu-4); CD3~5 CD3~ 
(mAb Sp64 [13], generously provided by Dr. C. Terhorst, Harvard 
University,  Boston, MA); TCR-3 (3F1; T Cell Sciences,  Cambridge, 
MA); TCR-~5 (~-TCS1; T  Cell Sciences); TCR-ot (c~F1; T  Cell 
Sciences); (CD3~"  (TIA-2 [14], generously provided by Dr. P. An- 
derson, Dana Farber Cancer Institute, Boston, MA); CD4 (anti- 
Leu-3a); CD5 (anti-Leu-1); CD6 (MB-G6, American Type Cul- 
ture Collection [ATCC], Rockville, MD); CD7 (anti-Leu-9);  CD8 
(anti-Leu-2b); CD10 (anti-Calla); CDlla (L7); CDllb (anti-Leu- 
15); CDllc (anti-Leu-MS); CD14 (anti-Leu-M3); CD15 (anti-Leu 
M1); CD16 (anti-Leu-lla);  CD18 (anti-LFA-l~); CD19 (anti- 
Leu-12); CD25 (anti-IL-2R-cz, BD); CD33 (anti-Leu-Mg); CD34 
(QBend/10.4.19; AMAC, Westbrook, ME); CD38 (anti-Leu-17); 
CD44  (anti-Leu-44); CD45  (anti-common  leukocyte antigen); 
CD45RA (anti-Leu-18); CD45KO (UCHL-1); CD56 (anti-Leu- 
19 and L185); CD57 (anti-Leu-7); CD69 (anti-Leu-23); CD71 (anti- 
transferrin receptor); glycophorin A (10F7Mn, ATCC); p75 II~2R 
protein (TU-27 [15], generously provided by Dr. K. Sugamura, 
Sendai,  Japan); Leu-8 (anti-Leu  8); HLA-DK (anti-HLA-DR, BD); 
and TdT (anti-TdT; Supertechs, Bethesda, MD). All mAbs were 
generously provided by  Becton Dickinson  Immunocytometry 
Systems (San Jose, CA), unless otherwise noted. Fluorochrome- 
conjugated rat anti-mouse Ig isotype-specific  mAbs were gener- 
ously  provided by  Mr.  David Buck  (Becton Dickinson  Im- 
munocytometry Systems). 
Immunofluorescence  andFlow Cytometry.  Cells  were stained  with 
fluorochrome-conjugated  mAb for detection of cell surface antigens 
by immunofluorescence, as described (16). Appropriate-purified 
or  fluorochrome-conjugated isotype-matched control  Igs  were 
used in all experiments. Samples were analyzed using a FACScan* 
(Becton Dickinson & Co.). 
For detection of cytoplasmic CD3 and TCK proteins in fresh 
fetal NK cells, cells were first stained with an IgM isotype anti- 
CD56 mAb (clone L185), followed by a PE-conjugated rat anti- 
mouse IgM isotype-specific  mAb. The cells were fixed for 10 min 
in ice-cold  acetone, rehydrated  for 20 min in PBS, and washed twice 
in wash buffer (PBS, pH 7.3, with 0.05% sodium azide and 2% 
FCS). Fixed  cells were stained for 30 min with optimal amounts 
of purified mAb to detect cytoplasmic antigens, washed twice in 
wash buffer, and then stained for an additional 30 min with op- 
timal amounts of FITC-conjugated antibodies specific  for the iso- 
types of the mAbs used for the detection of the cytoplasmic an- 
tigens (anti-mouse IgG1 and anti-mouse IgG2). 
For the detection of  TdT, viable cells stained with PE anti-CD56 
(as described above) were fixed for 30 min at 4~  in 1% parafor- 
maldehyde PBS (pH 7.3) and then incubated an additional 5 min 
in 0.1% (final concentration) triton X-100 (Sigma Chemical Co., 
St. louis, MO). The fixed cells were washed twice in wash buffer 
and  then  stained with  FITC-conjugated  anti-terminal  deox- 
ynucleotidyl transferase (TdT) according to manufacturer's recom- 
mendations. 
Purification of NK Cells.  NK cells were isolated either by posi- 
tive selection using FACS* or by negative depletion of other cell 
types using antibody-coated magnetic beads. For cell sorting ex- 
periments, cells  were stained  with a PE-conjugated  anti-CD56 mAb 
and an FITC-conjugated anti-CD3e mAb, and mCD3e-,CD56 § 
lymphocytes were isolated to >98% purity using a FACStar Plus* 
flow cytometer (Becton Dickinson & Co.), as previously  described 
(12). For magnetic  bead depletion, cells suspended  in PBS containing 
0.1% sodium azide were stained for 20 min on ice with saturating 
quantities of anti-CD3, CD4, CD5, CD14, CD19, CD33, CD71, 
and glycophorin A mAbs (all of which had been predetermined 
not to react with the cell surface of fetal NK cells). After staining, 
cells were washed extensively  and combined with magnetic beads 
coated with sheep anti-mouse IgG (Dynal Inc., Great Neck, NY), 
according to manufacturer's recommendation. 
NK cells  were cloned at one cell  per well using a single  cell depo- 
sition system of the FACStar Plus* flow cytometer. Clones were 
established using culture conditions described previously (17), and 
cloning efficiencies  were generally 10-20%. All clones generated 
by this procedure were mCD3e- ,CD56 + and mediated NK cyto- 
lytic function. 
Cell-mediated Cytotoxicity.  Cytotoxic activity was measured in 
a standard 4-h SlCr radioisotope release assay (18). NK-sensitive 
targets  assayed were K562 (erythroleukemia) and  Jurkat  (T 
leukemia). NK-resistant targets were Colo-205 (colon carcinoma), 
Colo-320 (colon carcinoma), JY  (EBV-transformed B lympho- 
blastoid cell), SB (EBV-transformed  B lymphoblastoid  cell), Ramos 
(Burkitt's lymphoma), Arent (EBV-transformed  B lymphoblastoid 
cell), Raji (Burkitt's lymphoma), and RMPI 8866 (myeloma). All 
tumor cell lines were obtained from ATCC, except Arent, which 
was generously  provided  by Dr. Ed Engleman (Stanford  University). 
Antibody-redirected killing assays using the FCR-bearing mouse 
P815 tumor cell line were performed as previously described (19). 
PCR.  RNA was isolated as described  by Chirgwin et al. (20), 
with minor modifications,  eDNA was prepared in a 40-/~1 reaction 
volume containing 50 mM Tris-HC1, pH 8.3, 50 mM KC1, 10 mM 
MgC12,  1 mM DTT, 1 mM EDTA, 0.1  /xg/ml BSA, 1 mM 
dNTPs,  2  mM  spermidine, 70  U  KNAsin (Promega Biotec, 
Madison, WI), 0.4 mM Na pyrophosphate, 10 U AMV reverse 
transcriptase (Pharmacia  Fine Chemicals,  Piscataway,  NJ), and 10 #g 
of total RNA. The reaction mixture was incubated at 42~  After 
45 min, KNA was hydrolyzed  by adding 40 #1 0.3 N NaOH and 
30 mM EDTA, and boiling for 5 min. eDNA was phenol/chloro- 
form extracted and ethanol precipitated. PCR were performed (43 
cycles at 94~  for I min; 55~  for I rain; 72~  for I min) using 
a GeneAmp Kit (Perkin-Elmer Cetus, Norwalk,  CT).  Primers 
for PCK were: CD3e, 5'AGTTC~CG~AAGA.W~T- 
AATGAAGAAAY and 5'CCCAGGAAACAGC~AGTCGCAGG- 
GGGACTGGAGAG3';  CD3c5, 5'TGCAATACCAGCATCACATG- 
GGTAGAGGGAACGGT3'  and 5'CTTGTTCCGAGCCCAGTTT- 
CCTCCAAGGTGC,  CTGT3'; CD3% 5'AACCACTCCAAGTGT- 
ATTACAGAATGTGTCAGAAC3'  and 5'ATICCTCCTCAACTG- 
GTTTCCTTGAAGGq'GC~TGT3'; CD3~', 5'TGGAAC,  GCGCT- 
TTTCACCGCGGCCATCCTGCAGGC3'  and 5'GCGAGGC,  C,G- 
CAGGC~CTC~ATGTGAA~GTCGT3'; CD4, 5'GCTGAT- 
GCTGAGCTTGAAACTGGAG3'  and 5'GCTACATGTCTTCTG- 
AAACCGGTGAG3'; B2-microglobulin, 5'T TAAGCTTCTrTC- 
TGGCCTTGAGGCT3' and 5'TATTCTAGATGGAGCAACCTG- 
CTCAGA'3. 
Southern Blot Analysis.  Genomic  DNA was isolated from NK 
clones, digested with restriction enzymes, transferred to nitrocel- 
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as described (21). 
Iraraunotnecipitation and Western Blot Analysis.  For Western blot 
analysis, cells were washed in PBS and then lysed at 10  s ceUs/ml 
in Tris-buffered  saline (TBS; 50 mM Tris, 150 mM NaC1, pH 8.0) 
containing  1%  NP-40, 20 Kallikrein inhibitor  U/ml aprotinin 
(Sigma Chemical Co.), and 1 mM PMSF (Sigma Chemical Co.) 
(22). After incubation for 20 min on ice, nuclei were pelleted by 
centrifugation (13,000 g) for 5 min, and lysates were added to an 
equal volume of2x Laemmli  sample buffer (23) containing 10% 
2-ME. Samples were incubated in a boiling water bath for 5 min. 
20/~1 of cell lysate containing 106 cell equivalents was subjected 
to dectrophoresis using 12% acrylamide gels (Bio-Rad Laborato- 
ties, Richmond, CA) and transferred (100 V, 1 h) to Immobilon-P 
membranes (Millipore Continental Water Systems, Bedford, MA) 
using transfer buffer (25 mM Tris, 192 mM glyeine, 20% meth- 
anol). Membranes were incubated overnight at 4~  on a orbital 
shaker platform in 100 ml blot buffer (10 mM Tris, pH 8.0, 150 
mM  NaC1, 0.02%  NAN3, 0.05%  Tween-20) containing  5% 
nonfat dry milk. Membranes were then incubated in 25 ml blot 
buffer containing 5% nonfat dry milk and 5/~g/ml affinity  purified 
rabbit anti-CD3e peptide antibody or 1/500 dilution of  anti-CD38 
mAb SP64 for 2 h at room temperature on an orbital shaker plat- 
form. After washing four times for 5 min in 100 ml blot buffer, 
membranes were incubated for I h at room temperature in 25 ml 
blot buffer containing 0.5/zCi/ml 12SI-labded protein A (for de- 
tection  of rabbit  antibody)  or  0.2  /~Ci/ml  12SI-labeled sheep 
anti-mouse  Ig (for detection of SP64 mAb) (Amersham Corp., 
Arlington Heights, IL). Membranes were washed four times for 
5 min in 100 ml blot buffer, rinsed in distilhd water, and autoradio- 
graphed. Affinity-purified  rabbit anti-CD3e peptide antibody was 
purchased from Dako (Denmark) and was generated against amino 
acids 156-168 (RKGHHLFPT(~MSP) in the cytoplasmic  domain 
of human CD3e (24). 
Results 
Ident~cation of NK Cells in Embryonic and Fetal T~sues. 
Flow cytometric analysis was used to identify the presence 
and frequency of NK cells in embryonic and fetal tissues. Re- 
markably, a substantial proportion of the mononuclear cells 
isolated from livers of 6-24 wk gestation expressed the pheno- 
type of adult NK cells (e.g., mCD3e-,CD56+).  As early as 
6 wk gestation, 5-8% of the total mononuclear cells were 
mCD3e-,CD56 +. Between 8 and 18 wk gestation, the total 
percentage of mCD3e-,CD56 + cells gradually increased to 
15-25%.  Representative data are presented in Fig.  1 A. It 
should be noted that while we have previously reported the 
presence  of a small subset of mCD3e +,CD56 + T  lympho- 
cytes in adult blood (9),  we never detected the presence  of 
CD56 + T cells in any fetal tissues, mCD3e +  ,CD56- T lym- 
phocytes were initially observed in fetal liver at •15-16  wk 
gestation and comprised 1- 2% of total liver cells. The propor- 
tion of T cells gradually increased through 18 wk gestation. 
Analysis of mononuclear cells from 20-24-wk fetal livers re- 
vealed equal percentages of NK and T  cells based on flow 
cytometric analysis ('~15-20%;  data not shown). NK cells 
were also identified in umbilical cord blood obtained at birth 
from healthy full-term neonates. Approximately 10-15% of 
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Figure 1.  Antigenic  phenotype  of embryonic, fetal,  and newborn NK 
cells. (A) Mononuclear  cells  were  obtained  from  embryonic  and fetal  livers 
at various gestation  ages and stained  with PE-conjugated  anti-CD56 and 
HTC-conjugated  anti-CD3r mAb. Cells were analyzed  by flow cytom- 
etry. Two-cdor contour maps (four-decade  log scales) displaying  FITC 
and PE fluorescence  were divided  into quadrants based on >95% of the 
calls residing  in the lower  left  quadrant  after  staining  with isotype  control 
mAbs. Of the total mononuclear  liver cells, NK ceils (mCD3e-,CD56  +) 
comprised 8% at 6 wk gestation, 11% at 10 wk gestation, 16% at 15 
wk gestation, and 18% at 18 wk gestation. The small  finger  of low den- 
sity  double  staining  cells  at a 45 ~ angle  from  the lower  left  quadrant  repre- 
sent nonspecific  staining  and are present in isotype  control  tubes. (B). Low 
buoyant  density  lymphocytes  were  isolated  from  newborn  cord  blood  and 
adult peripheral blood and stained as in A. Approximately  35% of the 
low buoyant  density  cells from newborn cord blood (left) and 40% from 
adult peripheral blood (right) were identified  as NK cells (mCD3~-, 
CD56*). 
cord lymphocytes were NK cells, comparable with their fre- 
quency in adult blood. Moreover like adult NK cells, cord 
blood NK cells preferentially migrated with the low buoyant 
density cells on Percoll gradients where they comprise 35--60% 
of lymphocytes depending on the donor (Fig.  1 B). At least 
1057  Phillips  et al. three embryos or fetuses were examined for each gestational 
age shown. 
The total mononuclear cell population isolated from fetal 
livers consisted of enucleated erythrocytes and leukocytes, as 
well as other cell types of unknown origin. Therefore, to 
estimate the frequency of NK cells within the leukocyte popu- 
lation, we determined the frequency of NK cells within the 
population of cells expressing the common leukocyte antigen 
CD45. This was accomplished by simultaneous three-color 
immunofluorescence  using PE-conjugated anti-CD56, FITC- 
conjugated anti-CD3e,  and peridinin chlorophyll protein 
(PerCp)-conjugated anti-CD45.  By this analysis, NK cells 
comprised from 35 to 70% of the CD45-positive leukocytes 
in embryonic/fetal livers of 6-24 wk gestation (Fig. 2). NK 
cells were also observed in fetal spleens between 15 and 24 
wk gestation, where they comprised 15-30% of the CD45 + 
cells (Fig. 2 B). NK cells were not readily observed in fetal 
thymus specimens between 16 and 24 wk gestation (Fig. 2 C). 
Freshly Isolated Fetal NK Cells Possess Spontaneous and IL,2- 
induced Cytolytic Function.  NK cells were purified from fetal 
liver (15-24 wk gestation), newborn cord blood, and adult 
peripheral blood by flow cytometry, and were assessed for 
cytolytic activity against NK-sensitive tumor cell targets (K562 
and Jurkat) and an NK-resistant  tumor cell target (Colo-205) 
in a 4-h radioisotope release assay. Freshly isolated fetal NK 
ceils demonstrated significant cytolytic activity against NK- 
sensitive tumor cell targets (Fig.  3 A). However,  the level 
of cytotoxicity of fetal NK cells was lower than that observed 
for newborn or adult NK cells (Fig. 3 B). In general,  lytic 
activity of the purified liver NK cell populations increased 
with age of gestation. 
Overnight incubation of fetal, newborn, or adult NK calls 
in rib2 (50 IU/ml) resulted in substantial augmentation of 
cytolytic activity (Fig. 3, C and D). Fetal liver NK cells de- 
rived from 15 and 18 wk gestation did not demonstrate the 
magnitude of cytotoxicity observed for 24-wk gestation NK 
calls or newborn NK cdls, particularly against NK-resistant 
tumor cell targets. 
Since a substantial  percentage of fetal NK cells expressed 
CD16 (Fc3,RIII)  at low levels on the cell surface (30-50% 
of total NK cells depending on the donor), assays were per- 
formed to determine if this molecule was competent to trigger 
cytolytic activity, mAbs against CD16 have been shown to 
initiate cytotoxicity against Fc receptor-bearing NK-resistant 
targets (19). Purified fetal liver NK cells (18 wk gestation), 
newborn cord blood NK cells, and adult peripheral NK cells 
were combined with 51Cr-labeled murine P815 tumor cells 
precoated with either a nonreactive isotype control mAb, anti- 
CD16 mAb, or anti-CD56 mAb, and incubated for 4 h at 
37~  Results from these experiments clearly showed that 
the CD16 molecule on fetal NK cells could efficiently signal 
cytotoxicity (Fig. 4). The magnitude of cytotoxicity was less 
for fetal NK cells than that observed for either newborn or 
adult NK cell populations; however, this may be accounted 
for by the lower percentage of fetal NK cells expressing CD16. 
Cytoplasmic Expression of CD3 Proteins.  Results from these 
studies have established  that the freshly isolated mCD3e-, 
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Figure 2.  Antigenic phenotype of NK cells in fetal liver, spleen, and 
thymus. Mononuclear cells were isolated from liver (A), spleen (B), and 
thymus (C) obtained from a 16 wk gestation fetus. Cells were stained 
and analyzed as described in Fig. 1. Approximately 38% of liver, 32% 
of spleen, and <1% of thymus cells were NK cells (mCD3E-,CD56 § ). 
Similar results were obtained from fetuses of 18 and 20 wk gestation. 
CD56 § lymphocyte population present in fetal hematopoi- 
etic tissues mediates spontaneous and IL-2-induced MHC- 
unrestricted cytotoxicity against tumor cell targets and pos- 
sesses ADCC function. Adult NK cells have been previously 
reported to express CD3~" protein in association with CD16 
(11, 25), but to lack membrane and cytoplasmic expression 
of CD3E proteins (26). To compare fetal with adult NK cells, 
freshly isolated fetal liver, fetal spleen, newborn cord blood, 
and adult peripheral blood NK cells were stained with PE- 
conjugated anti-CD56 mAb, fixed, and costained to detect 
the presence of cytoplasmic CD3 proteins. Consistent with 
previous studies, adult NK cells expressed cytoplasmic CD3~" 
protein and did not stain with anti-CD3e or anti-CD36 mAb 
(Fig. 5 C). Surprisingly, the majority (50-80%) of fetal NK 
ceils showed prominent expression of CD3e, CD3/t, and CD3~" 
proteins (Fig. 5 A). In the example shown in Fig. 5, careful 
examination of the fluorescence histograms of fetal NK cells 
stained for cytoplasmic CD3e revealed that a small propor- 
tion ("~20%)  lacked  detectable  CD3e,  whereas the cyto- 
plasmic CD3e-positive NK cells demonstrated two distinct 
levels of protein expression. Cytoplasmic CD3e proteins were 
detected in both the CD16-  and CD16 + subsets of fetal NK 
cells (data not shown). The majority of fetal NK cells also 
expressed detectable levels of cytoplasmic CD3~ protein, in- 
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Figure 3.  Freshly isolated fetal and newborn 
NK cells demonstrate spontaneous  and IL-2- 
induced  cytotoxicity. NK cells were purified 
from 15, 18, and 24 wk gestation fetal livers 
(.4), newborn cord blood, and aduh  periph- 
eral blood (B), and were assayed for cytotoxic 
activity.  The same purified populations were 
also activated overnight in the presence of 50 
U/ml of rlb2 and then assayed for cytotoxic 
capabilities.  E/T ratio  was 25:1. 
dicating that most must coexpress  both CD3/~ and CD3e. 
In most fetal tissues examined, the proportion of cytoplasmic 
CD3e-positive fetal NK cells exceeded the frequency of CD3/~- 
positive cells, suggesting the possibility  that CD3e + ,~-  NK 
cells may exist. As was observed for adult NK cells,  essen- 
tially all fetal NK cells expressed cytoplasmic CD3~" protein. 
Analysis of cytoplasmic CD3 proteins in newborn cord blood 
NK cells also revealed the presence of a small proportion of 
NK cells  expressing CD3e  and CD3/~ proteins (Fig.  5 B). 
The percentage  of newborn NK cells expressing CD3E and 
CD3~ was extremely variable from donor to donor.  Using 
mAbs against CD3e and CD3~, we have never observed cy- 
toplasmic CD3E or CD3~ in adult NK cells,  mAb specific 
for CD33' were not available to determine expression of this 
subunit in freshly isolated fetal tissues. Cytoplasmic staining 
with  mAbs  against  framework  determinants  of TCR-o~, 
TCR-B, and TCR-~ failed to reveal these proteins  in either 
fetal or  adult NK cells  (data not shown). 
To determine if the CD3 proteins  were stably expressed 
in fetal NK cells,  long-term (>4 too) clones of mCD3e-, 
CD56 + fetal liver NK cells were established using a FACS  | 
single cell cloning system. Over 100 individual fetal NK cells 
clones were established  and analyzed for cytolytic function, 
cell surface antigenic phenotype, and the expression of cyto- 
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plasmic CD3 proteins.  The majority  of these clones (70%) 
expressed cytoplasmic CD3e, CD3~, and CD3~'proteins  (Fig. 
6 B). Approximately 10% of the fetal NK cell clones expressed 
CD3E and CD3~', but no detectable CD3~. The remaining 
20% of fetal NK clones expressed only CD3~" protein (Fig. 
6 A), which was characteristic of all adult peripheral blood 
NK  cell  clones.  Both  CD16-  and CD16 +  fetal  NK  cell 
clones have been generated, and cytoplasmic CD3e and ~ pro- 
teins are variably expressed in both types of NK cell clones 
(data not shown). Regardless of the expression of cytoplasmic 
CD3 proteins,  all fetal NK clones were mCD3E-,CD56 + 
and demonstrated a very similar spectrum of cytolytic activity 
against a broad panel of tumor cell targets (two representa- 
tive clones are presented  in Fig.  7). 
Analysis of TCR Rearrangement, CD3 Transcription,  and CD3 
Protein Expression in NK Clones.  Fetal NK clones were ana- 
lyzed by PCR for the presence of transcripts of CD3% CD3/~, 
and CD3e.  Primers  for  ~z-microglobulin  and CD4  were 
used as a positive and negative controls,  respectively. Results 
from representative clones are shown in Fig. 8. All fetal NK 
clones examined expressed CD3E transcripts, consistent with 
prior observations  using adult NK clones (26). Several fetal 
NK clones expressed CD3/~ transcripts, in accordance with 
and confirming the results from the cytoplasmic  staining ex- Figure 4.  Freshly  isolated  fetal and newborn NK cells  mediate anti-CD16- 
dependent redirected  cytotoxicity. NK cells  were purified from 18 wk gesta- 
tion fetal liver, newborn cord blood, and adult peripheral blood by flow 
cytometry, and assayed for redirected cytolysis of P815 tumor cells in the 
presence of 10/~g/ml of isotype control, anti-CD56, or anti-CD16 mAb. 
periments. CD33' transcripts were either absent or present 
in only very low levels in most fetal NK clones,  including 
some clones that expressed high levels of cytoplasmic CD3e 
and CD35. However, CD33, transcripts were detected in cer- 
tain fetal NK clones (e.g., NKBl.11).  Representative fetal NK 
clones were analyzed for rearrangement of TCR-3 and TCR-y 
genes,  and all were found to be in germline configuration 
(Fig.  9). 
Western blot analysis  was performed to confirm results from 
the PCR and immunofluorescence experiments. As shown 
in Fig.  10, the presence of CD3e and CD3/i proteins of the 
appropriate molecular weight were detected in lysates of fetal 
NK clones NKB1.6, NKB1.13, NKB1.18, NKBl.11, and cord 
Fetal NK cells were assayed at an E/T ratio of 25:1, while newborn and 
adult NK E.'T was 12:1. NK cells were >95% pure based on reanalysis 
of the sorted NK cell populations. 
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Figure 6.  Expression  of cytoplasmic  CD3 proteins in fetal  NK cell  clones. 
mCD3e-,CD56 + fetal NK cell clones were established as described in 
Materials and Methods and maintained in culture for >4 too. Analysis 
of CD3 protein expression is displayed  for two representative  clones. Fetal 
NK clone NKA1.4 (A) is representative of those clones expressing only 
cytoplasmic CD3~', which is typical for all NK cell clones derived from 
adult peripheral blood. Approximately  20% of fetal NK cell clones ex- 
pressed only CD3~'protein. The majority of fetal NK cell  clones  expressed 
cytoplasmic CD3e, CD3~, and CD3~"  proteins (B). Approximately  70% 
of fetal NK cell clones (n >  100) expressed  cytoplasmic  CD3 proteins simihr 
to clone NKBl.11. 
blood NK clone CB.9. CD3 proteins were detected in Jurkat 
T leukemia cells (positive control), but not in Ramos or Raji 
Burkitt's lymphoma cells (negative controls). 
Comparative Studies of Antigenic Phenotypes of Fetal and Adult 
NK Cells.  Since the expression of cytoplasmic CD3e,8 pro- 
teins in embryonic and fetal NK cells clearly distinguishes 
them from adult NK cells, we analyzed freshly isolated fetal 
and adult NK cells by three color immunofluorescence using 
a  comprehensive  panel  of mAbs  against  other  leukocyte 
differentiation antigens. Fetal liver mononuclear cells of 13-18 
wk gestation were compared with low buoyant density cord 
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Figure 7.  Cytotoxic  activity  of fetal  NK cell  clones. Fetal  NK cell clones 
described in Fig. 4 were assayed  for cytotoxic  activity  against a broad panel 
of tumor cell targets in a 4-h slCr release assay. E/T was 3:1. 
blood and adult PBL (enriched for NK cells). By placing an 
electronic  gate  on  mCD3e-,CD56 +  lymphocytes,  it  was 
shown that NK cells derived from fetal liver, cord blood, and 
adult peripheral blood displayed remarkable phenotypic similar- 
ities. NK cells, regardless of their source, did not express sur- 
face CD1, CD4, CD5, CD6, CD10, CD14, CD15, CD19, 
or CD45RO.  Moreover, they did not express the hemato- 
poietic progenitor antigen, CD34, nor did they express (TdT). 
Like adult NK cells, most fetal and cord blood NK cells ex- 
pressed  CD2,  CD7,  CD11a-c,  CD18,  CD38,  CD45,  and 
CD45RA, as well as the p75 IL2R (data not shown). Con- 
sistent with prior reports,  CD57 was not found on fetal or 
cord blood NK cells (27), but was detected on "~,50% of adult 
NK cells (18). In contrast, the CD69 antigen, which has been 
characterized as an inducible lymphocyte activation antigen, 
was  prominently expressed  on  all  fetal NK  cells  and  the 
majority of cord blood NK cells (Fig.  11). 
Previously, we have reported that distinct subsets of adult 
peripheral blood NK cells can be identified based on the pres- 
ence or absence of CD16 expression and the relative amount 
of CD56 (9, 28). Interestingly, fetal and newborn NK cells 
generally expressed slightly higher surface density of the CD56 
antigen than was observed on the majority of adult periph- 
eral blood NK cells (Fig. 1). Although CD16 was expressed 
on >90% of adult and newborn NK cells, fetal NK cells from 
either the liver or spleen generally expressed this antigen on 
"~30-50%  of the cells  (Fig.  11 A).  The CD16  antigen on 
fetal NK cells was present in low surface density compared 
with the high surface expression of this antigen on newborn 
and adult NK cells.  Phenotypic analysis of cord blood lyre- 
Figure 5.  Expression  of cytoplasmic  CD3 proteins in freshly isolated NK cell populations. Mononuclear  cells isolated from 16 wk gestation fetal 
liver (A) and cord blood low buoyant density cells (B), and adult peripheral blood low buoyant density  cells (C) were surface  stained  with PE-conjugated 
anti-CD56 mAb, fixed, permeabilized, and stained for cytoplasmic  CD3e,~, and ~'. By setting a gate on the CD56-positive cells, the percentage of 
cells expressing CD3 subunits was determined. In this fetal liver (/t), ',~85% of NK cells expressed cytoplasmic  CD3e, 60% expressed CD3~, and 
97% expressed CD3~"  proteins. Approximately 15% of newborn cord blood NK cells (B) showed cytoplasmic  CD3e, 30% CD3~, and 95% CD3~" 
protein. Adult peripheral blood NK cells (C) demonstrated only cytoplasmic CD3~'. 
1061  Phillips  et al. Figure 8.  PCR analysis  of CD3 transcription. RNA was isolated  from 
a CD4 + T cell clone (TcB.1; positive  control), adult peripheral blood NK 
clone NKll, and fetal liver NK clones NKB1,6, NKA1.4, and NKAl.11. 
cDNA was generated and expression  of CD3e, CD3~, CD3'y, and CD4, 
and B2-microglobulin  was assayed  using appropriate primers. The arrow 
in each panel represents the expected size of the PCR product. 
phocytes also revealed  a significant population of mCD3e- 
lymphocytes that  expressed CD16, but did not express de- 
tectable  CD56  antigen  (Fig.  11  B).  These  cells  were also 
identified in fetal liver between 16 and 24 wk gestation at 
very low frequencies (<1%). The relationship of these cells 
to NK cells is at present unknown and needs further investi- 
gation. 
Discussion 
The antigenic and functional properties of mature NK cells 
from adults have been extensively investigated. Based on these 
studies, it is believed that NK cells are distinct from B and 
T  cells  and likely represent  a third lymphoid lineage (29). 
However, the developmental relationship  of B, T,  and NK 
cells has not been delineated, and lymphoid progenitor cells 
have  not been identified.  Therefore,  the primary  objective 
of the present study was to carefully analyze the lymphoid 
populations of the developing human embryo and fetus for 
the presence of NK cells or possible NK progenitor popula- 
tions. To our surprise, substantial numbers of NK cells were 
detected in all embryonic liver (6-9 wk gestation), fetal liver 
(9-23  wk gestation),  fetal  spleen,  and cord blood popula- 
tions  studied.  These NK cells were identified by the  same 
criteria  that  have been used to define adult  NK cells  (e.g., 
mCD3e-,CD56 +  lymphocytes),  and  like  adult  NK  cells 
populations contained both CD16-  and CD16 + subsets. By 
Figure 9.  Southern blot analysis of fetal NK clones. High molecular 
weight DNA was isolated from  JY (B lymphoblastoid  cell  line; germline 
control) and a panel  of  fetal  NK clones. 15/zg  DNA from  each  was digested 
with the indicated restriction enzyme and fragments were subjected to 
electrophoresis  through 1% agarose  gels. Membranes  were  hybridized  with 
radiolabeled C131 probe (41) or J71 PH60 (42) probes. 
contrast with these peripheral lymphoid tissues, a substan- 
tial proportion of NK cells was not observed in fetal or neo- 
natal thymus (<<1%). Moreover, we have shown that freshly 
isolated embryonic, fetal, and cord blood NK cells mediated 
MHC-unrestricted cytotoxicity against NK-sensitive tumors 
and acquired the ability to lyse NK-resistant tumors after over- 
night  culture with  IL-2. 
The antigenic and functional properties of embryonic and 
fetal NK cells are very similar to a small subset of adult NK 
cells we have previously described based on the phenotype 
mCD3e-,CD56b~s  ht  (9,  28).  This  population  comprises 
<1%  of PBL and was identified based on the observation 
that these cells expressed higher amounts of CD56 antigen 
and lower levels of CD16 than the majority of adult NK cells. 
Embryonic and fetal NK cells share a number of similarities 
1062  Human  Fetal Natural Killer Cells Figure 10.  Western  blot anal- 
)'sis of CD3 proteins. NP-40 de- 
tergent  lysates  were  prepared  from 
Ramos  (Burkitt's  lymphoma; 
negative  control),  Jurkat (T leu- 
kemia; positive  control),  and fetal 
liver NK clones. 106 cell equiva- 
lents of lysate were subjected  to 
electrophoresis  using 12% acryl- 
amide gels  and transferred  to Im- 
mobilon  membranes.  Membranes 
were  bbtted with affinity-purified 
rabbit anti-CD3e peptide anti- 
body  or mouse  anti-human  CD3~5 
mAb SP64, as indicated.  Bound antibody  was detected  using lzSI-labeled 
protein A or sheep  anti-mouse  Ig, respectively.  Proteins  of the predicted 
molecular  weight of CD3e and CD3c5 are indicated  by the arrow  in each 
panel. Raji, another  Burkitt's lymphoma  used  as a specificity  control, was 
also negative (not shown). 
with  the  CD56 bright NK  cell  subset  in  adult  peripheral 
blood: (a) both express high surface density CD56 and lack 
or express only low levels of CD16; (b) neither express CD57; 
(c) both express high affinity IL-2Rs and respond to low con- 
centrations of IL-2; and (d) both display lower constitutive 
cytolytic activity against NK-sensitive targets than the majority 
of circulating NK cells.  We have previously proposed that 
the CD56b~ig  ht  NK  cells  may represent  a  more immature 
stage of NK cell differentiation (9, 28). The numerous similar- 
ities  between  fetal  NK  cells  and  adult  peripheral  blood 
CD56  baght NK cells  add support  to  this  hypothesis; how- 
ever, further studies are required to determine if they are related 
to a common differentiation pathway. However, an impor- 
tant distinction is that adult peripheral blood CD56bns  h~ NK 
cells do not express cytoplasmic CD3e or CD3/~, but do ex- 
press CD3~',  as determined by immunofluorescent staining 
using mAbs against these structures (J. Phillips and L. Lanier, 
unpublished observation). 
While prior studies on the existence and function of NK 
cells in the human fetus have been contradictory and of  limited 
scope (30-32),  our present results clearly demonstrate that 
NK ceils arise very early during embryogenesis and that fetal 
NK cells are capable of  both spontaneous MHC-unrestricted 
cytotoxicity and ADCC.  Since maternal  Ig can cross  the 
placenta, NK cell-mediated ADCC may represent a significant 
immunological defense mechanism against viral and bacterial 
infections, before acquisition of T cell-mediated cellular im- 
munity. While we have not as yet analyzed freshly isolated 
fetal NK cells for the capacity to produce cytokines, fetal NK 
clones do possess the ability to secrete IFN-% GM-CSF, and 
TNF-ot (H. Spits,  T. Hori, and J. Phillips,  unpublished ob- 
servations). Thus, it is conceivable that NK cells provide a 
source of cytokines that may influence development and func- 
tion of the fetal immune and hematopoietic systems. Due 
to the difficulty in obtaining human embryonic tissue before 
6 wk gestation, we were unable to determine exactly when 
NK cells initially become detectable in the developing em- 
bryo. It is tempting to speculate that NK cells may initially 
arise from the primitive blood islands of the yolk sac during 
the very first wave of hematopoiesis. 
Clearly the most unexpected feature of embryonic/fetal NK 
cells was the prominent expression of cytoplasmic CD3e and 
CD3/~ proteins. While CD3~" has been shown to coassociate 
with CD16 in NK cells (11, 25), adult NK cells from both 
mice and humans have been reported to lack expression of 
other CD3 subunits (6, 26).  Moreover, although low levels 
of CD3~,  but  not  CD3~  or  CD3%  mRNA  have been 
identified in adult human NK clones, there has been no evi- 
dence for expression of CD3e protein in these cells (26). Our 
present findings show that the majority of embryonic and 
fetal human NK cells and a small percentage of newborn cord 
blood NK cells express CD3e, CD3~, and CD3~'cytoplasmic 
antigens. We have confirmed the expression of CD3e  and 
CD3~ in the fetal NK clones by immunofluorescence, PCR 
detection of transcripts, and Western blot analysis. Unfortu- 
nately, we were unable to directly assess the expression of 
CD33, antigen in fetal NK cells, since anti-CD33' reagents 
that could detect cytoplasmic protein by immunofluorescent 
staining were unavailable.  However, PCR analysis  revealed 
the presence of CD37 transcripts in some fetal NK clones, 
whereas CD33' mRNA was essentially undetectable in other 
clones. Preliminary studies using an anti-CD33, peptide an- 
tiserum for Western blot analysis  failed to detect a mature 
CD33, glycoprotein in lysates prepared from fetal NK clones 
that expressed abundant CD3e and CD3~ cytoplasmic pro- 
teins (L. Lanier and J.  Phillips,  unpublished observations). 
However, further quantitative analysis of CD33~ mP,  NA ex- 
pression and a careful study using specific anti-CD33/anti- 
bodies is certainly required before it is appropriate to make 
any definitive conclusions. 
The expression of CD3  subunits in fetal NK cells is an 
intriguing observation, particularly since the expression of 
cytoplasmic CD3e has been previously been used as an un- 
ambiguous marker to assign malignant and normal lympho- 
cytes to the T lineage. It should be noted that all of the em- 
bryonic and fetal NK cells examined expressed CD7. Haynes 
et al.  (33) have previously used immunohistochemical tech- 
niques to describe a population of lymphocytes in fetal liver 
and spleen with the phenotypes CD45 +, CD7 +, and cyto- 
plasmic CD3e +. They have proposed that these cells repre- 
sent pre-T cells that are committed to the T lineage and are 
destined for migration to the thymus. While some cells of 
this phenotype may be pre-T cells, our present finding would 
suggest that this population contains a substantial propor- 
tion of functionally competent NK cells that do not repre- 
sent progenitors committed to the T  cell lineage. Evidence 
in support of this hypothesis can be summarized as follows. 
(a) Most CD7 +  ,CD45 + lymphocytes in fetal liver coexpress 
CD56.  While CD56 can be expressed on a small subset of 
adult peripheral blood T  cells (9), mCD36 § ,CD56 + T  cells 
were essentially undetectable in  all  fetal  tissues,  including 
thymus. Moreover, mCD3- ,CD7 +  ,CD45 + thymocytes do 
not express CD56  (34).  (b) The population  of mCD3e-, 
CD56 +  (CD7 +,CD45 +)  fetal  lymphocytes demonstrated 
spontaneous and IL-2-activated NK cytotoxicity and ADCC. 
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Figure 11.  Two-color antigenic phenotype of fetal, newborn, and adult 
NK cells. Mononuclear leukocytes from a 16 wk gestation fetal liver (A), 
low buoyant density lymphocytes from newborn cord blood (B), and low 
buoyant density lymphocytes from adult peripheral blood were analyzed 
by two-color  immunofluorescence. In A,  there  were 20%  NK cells 
(mCD3e-,CD56 +) and 10% T cells (mCD3E  § ,CD56-). These NK cells 
did not express CD57, however, 50% expressed  low surface  density CD16, 
and 98% expressed CD69.  In B, 40% of the low buoyant density cord 
blood lymphocytes were NK cells. Newborn cord blood NK cells did not 
express CD57; however, they expressed low density CD69 and high sur- 
face density CD16 on the majority of cells. In C, 45% of the adult periph- 
eral blood low buoyant density cells were NK cells. In this donor, 70% 
of the NK cells expressed CD57,  98% expressed CD16, and <10% ex- 
pressed low surface density CD69. 
It seems unlike that undifferentiated progenitor cells would 
mediate these functions.  (c) Fetal mCD3e-,CD56 + NK cells 
did not express the CD34,  TdT, or HLA-DR+ proteins;  all 
of which have been associated with progenitor populations 
(35-38)  and  shown  to  be  expressed  on  mCD3-,CD7  +, 
CD45 §  thymocytes (34),  (d) lqone of the long-term clones 
established from the mCD3e-,CD56 + fetal liver population 
acquired expression of TCR proteins or rearranged TCR genes. 
All maintained  a stable NK antigenic phenotype and cyto- 
lytic function. 
1064  Human Fetal Natural Killer Cells Collectively, these results caution against using expression 
of cytoplasmic CD3 proteins as definitive markers of the T 
cell lineage. However, these observations do support the pos- 
sibility that NK and T  lymphocytes arise from a common 
progenitor, before rearrangement of TCR genes in the T lin- 
eage. We propose that this hypothetical progenitor may re- 
side in the fetal liver or adult bone marrow and give rise to 
(CD56-)  cells  that express  cytoplasmic CD33,,5,e,  and  ~" 
proteins, before commitment to the NK or T  lineage.  As 
a consequence of as yet undefined signals, cells destined for 
the T lineage migrate to the thymus and initiate rearrange- 
ment of the TCR genes. By contrast, it is possible that pro- 
genitor cells not receiving these instructions or possibly re- 
sponding to other stimuli downregulate expression of CD3c5, 
%  and e and become committed to the NK lineage.  If this 
hypothetical scheme is correct, CD33" may be downregulated 
first during commitment to the NK lineage, followed by loss 
of CD35 and CD3e proteins. In the majority of fetal NK 
ceils and in a minor subset of cord blood NK cells, expres- 
sion of  cytoplasmic CD3~5 and CD3e proteins persists, whereas 
both are apparently lost in the mature, adult NK popula- 
tions in blood and spleen.  An alternative possibility is that 
the cytoplasmic CD3~5,~  + fetal NK cells represent a distinct 
subpopulation of NK cells that is predominant in the fetus, 
but replaced by the cytoplasmic CD3/~,e-  adult NK popu- 
lation after embryogenesis, comparable to the "waves" of y/5- 
TCR and ot/3-TCIL T  cell populations that have been de- 
scribed during T cell development (39, 40).  The functional 
significance of CD3e and CD36 cytoplasmic proteins in fetal 
and cord blood NK cell is unknown. These may simply rep- 
resent vestigial structures that are slowly eliminated as a con- 
sequence of maturation after the hypothetical NK/T cell pro- 
genitor has committed to the NK lineage. 
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